← All Ac Immune SA filings

Ac Immune SA Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune Director Receives Equity Awards
AC Immune SA reports that Director Roy Ervin Twyman was granted restricted stock units and stock options on June 11, 2026.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune Director Receives Equity Awards
AC Immune SA director Renee Aguiar-Lucander was granted restricted stock units and stock options on June 11, 2026.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune SA: Director Receives Equity Awards
AC Immune SA reports that Director Martin Zuegel was granted restricted stock units and stock options on June 11, 2026.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune Director Acquires Shares and Options
AC Immune SA reports that Director Monika Buetler acquired 17,751 restricted share units and 41,667 share options.
NASDAQ
ACIU
Ac Immune SA
Form 4: Director Carl Howard Receives Equity Awards
AC Immune SA Director Carl Howard was granted restricted stock units and stock options on June 11, 2026, as disclosed in a Form 4 filing.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune CEO Sells Shares Under 10b5-1 Plan
AC Immune SA's CEO, Andrea Pfeifer, reported the sale of 10,000 common shares for $2.7935 each under a pre-arranged trading plan.
NASDAQ
ACIU
Ac Immune SA
4/A: AC Immune CEO Corrects Share Sale Filing
CEO Andrea Pfeifer filed an amendment to correct a previously misreported share transaction involving 10,000 shares.
NASDAQ
ACIU
Ac Immune SA
Form 4: AC Immune CEO Andrea Pfeifer Increases Stake in ACIU
CEO Andrea Pfeifer purchased 10,000 shares of AC Immune SA at a weighted average price of $3.1425 per share.